These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10975600)

  • 1. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
    Gonon AT; Gourine AV; Pernow J
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):405-12. PubMed ID: 10975600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion.
    Gourine AV; Gonon AT; Pernow J
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1105-12. PubMed ID: 11179053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion.
    Gonon AT; Gourine AV; Middelveld RJ; Alving K; Pernow J
    Basic Res Cardiol; 2001 Sep; 96(5):454-62. PubMed ID: 11605992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel non-peptide selective endothelin A receptor antagonist LU 135,252 protects against myocardial ischaemic and reperfusion injury in the pig.
    Gonon AT; Wang QD; Shimizu M; Pernow J
    Acta Physiol Scand; 1998 Jun; 163(2):131-7. PubMed ID: 9648631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium.
    Gourine A; Gonon A; Sjöquist PO; Pernow J
    Cardiovasc Res; 2001 Jul; 51(1):100-7. PubMed ID: 11399252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
    Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
    Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
    Gonon AT; Wang QD; Pernow J
    Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
    Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
    Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo.
    Gourine AV; Molosh AI; Poputnikov D; Bulhak A; Sjöquist PO; Pernow J
    Br J Pharmacol; 2005 Feb; 144(3):331-7. PubMed ID: 15655526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ET(A) receptor antagonist LU 135252 has no electrophysiological or anti-arrhythmic effects during myocardial ischaemia/reperfusion in dogs.
    Vágó H; Soós P; Zima E; Gellér L; Kékesi V; Andrási T; Szabó T; Juhász-Nagy A; Merkely B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():223S-227S. PubMed ID: 12193091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
    Shimizu M; Wang QD; Sjöquist PO; Rydén L
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.
    Gonon AT; Jung C; Katz A; Westerblad H; Shemyakin A; Sjöquist PO; Lundberg JO; Pernow J
    PLoS One; 2012; 7(7):e42038. PubMed ID: 22860052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
    Wang QD; Li XS; Lundberg JM; Pernow J
    Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
    Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
    Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide.
    Gourine AV; Pernow J; Poputnikov DM; Sjöquist PO
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):564-70. PubMed ID: 12352318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Endothelin-A antagonist LU 135 252 supresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling.
    Raschack M; Juchelka F; Rozek-Schaefer G
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S145-8. PubMed ID: 9595424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion.
    Tratsiakovich Y; Gonon AT; Kiss A; Yang J; Böhm F; Tornvall P; Settergren M; Channon KM; Sjöquist PO; Pernow J
    Int J Cardiol; 2013 Oct; 169(1):83-8. PubMed ID: 24067598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
    Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
    Pernow J; Wang QD
    Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.